IRCT20210326050772N1
Recruiting
Phase 2
Evaluation of the efficacy of Selenium supplementation therapy on the inflammatory markers oxidative stress and liver functional parameters in thalassemia major and intermediate
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Zanjan University of Medical Sciences
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Willingness to participate in the study
- •Having thalassemia major or intermedia
- •Having healthy liver and kidney function
Exclusion Criteria
- •History of chemotherapy
- •Take any supplements and vitamins at least two months before the study
- •Diabetic patients
- •Patients with acute and chronic infections
- •Having any inflammatory disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 3
Selenium supplementation in the treatment of hemodialysis patientsIRCT20170513033941N62Islamic Azad University40
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Phase 3
The effect of selenium on cancer related-fatigueCancer-related fatigue.Neoplasm-related fatigueR53.0IRCT20210825052293N1Esfahan University of Medical Sciences70
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failureIRCT138812043408N1Shiraz University of Medical Sciences80